2026 Movement Disorders Specialist Salary Guide: Parkinson's & DBS Physician Compensation

Movement disorders specialists are neurologists with fellowship training in Parkinson's disease, essential tremor, dystonia, Huntington's disease, ataxia, and related conditions. The subspecialty combines complex longitudinal outpatient management — titrating dopaminergic medications, managing motor fluctuations and dyskinesias, monitoring for non-motor complications — with procedural revenue from botulinum toxin injections and deep brain stimulation (DBS) programming. Total compensation in 2026 runs from $280,000 to $500,000, with the range driven by academic vs. private practice setting, DBS program affiliation, and botulinum toxin injection volume.

Salary overview by practice setting

• Academic neurology department (movement disorders division): $280,000–$400,000; NIH NINDS research funding (R01 for Parkinson's neuroprotection, biomarker studies); MDS and AAN leadership pipeline; alpha-synuclein/LRRK2/GBA genetics research; PSLF-eligible employment; post-doctoral training pipeline; clinical trial infrastructure for disease-modifying therapy development (PPMI, PRoBaND, STEADY-PD data sites)
• Academic-affiliated comprehensive movement disorders center: $330,000–$450,000; dedicated center infrastructure (Parkinson's Foundation Centers of Excellence, UCSF Weill Institute, Mayo Clinic Parkinson's, Cleveland Clinic Neurological Institute); multidisciplinary team (physical therapy, speech-language pathology, occupational therapy, social work, neuropsychology) drives quality and referral volume
• Community neurology practice with movement disorders focus: $350,000–$480,000; high-volume outpatient Parkinson's management; botulinum toxin injection in-office; may have DBS programming but not DBS implantation (which requires neurosurgery partnership); wRVU-based incentive; lower academic overhead; fastest path to high-income practice for movement disorders specialists
• Private neurology practice (movement disorders + general): $380,000–$510,000; botulinum toxin buy-and-bill as key income multiplier; DBS device programming revenue; movement disorders as referral magnet for general neurology panel; ancillary EMG and nerve conduction studies for differential diagnosis workup

Fellowship pathway

Movement disorders fellowship is typically a 1–2 year ACGME or non-ACGME clinical fellowship following neurology residency (4 years post-MD). UCNS certification in Movement Disorders is available for subspecialty recognition. Top fellowship programs include UCSF (Parkinson's Disease and Movement Disorders), Mayo Clinic, Cleveland Clinic, Northwestern, Johns Hopkins, Columbia, and Penn. Approximately 150–200 movement disorders fellows complete training annually — a pipeline that has grown but remains below replacement level for retiring movement disorders neurologists and below demand from an aging US population with rising Parkinson's disease prevalence (approaching 1 million Americans with PD).

Procedures and billing

Movement disorders physicians generate procedural revenue from botulinum toxin injection and DBS programming — two revenue streams that significantly elevate income above cognitive neurology median:

• Botulinum toxin injection — cervical dystonia: CPT 64616 (chemodenervation of muscle, neck); professional fee $500–$1,000; insurance-covered for cervical dystonia, spasmodic torticollis; J0585 (onabotulinumtoxinA per unit) buy-and-bill if physician supplies Botox directly (wholesale ~$5.50/unit, 200–300 units per treatment, charged to insurance at Medicare/commercial rate per unit); cervical dystonia patients typically treated every 3–4 months creating recurring revenue
• Botulinum toxin injection — limb spasticity: CPT 64642 (chemodenervation, extremity, 1–4 muscles) or 64644 (5+ muscles); professional fee $400–$900; upper and lower extremity spasticity from stroke, TBI, MS, CP; insurance-covered; high-volume in post-stroke spasticity management programs; buy-and-bill margin applies when physician supplies drug
• Botulinum toxin injection — focal hand dystonia (writer's cramp): CPT 64642; professional fee $400–$800; intrinsic hand muscle injection for task-specific dystonia; requires EMG guidance (CPT 95874 add-on for EMG-guided injection, professional fee $200–$400) to precisely target affected muscles; specialist skill differentiator
• Botulinum toxin injection — blepharospasm/hemifacial spasm: CPT 64615 (bilateral facial muscles); professional fee $500–$1,000; insurance-covered; as described in oculoplastic guide; every-3-month repeat schedule
• Botulinum toxin injection — sialorrhea (drooling in Parkinson's): CPT 64611 (chemodenervation of salivary glands); professional fee $400–$800; parotid and submandibular gland injection; FDA-approved for chronic sialorrhea associated with neurological conditions; buy-and-bill applies; growing indication as awareness increases
• Deep brain stimulation (DBS) programming: CPT 95983 (DBS programming, initial contact); professional fee $500–$1,200; CPT 95984 (DBS programming, subsequent, per 15 min increment); professional fee $200–$500 per 15-minute increment; DBS programming is the neurologist's role post-implantation (neurosurgery implants, neurology programs); Parkinson's DBS (STN or GPi target), essential tremor DBS (VIM target), dystonia DBS (GPi target); adaptive/closed-loop DBS programming (Medtronic Percept, Abbott Infinity) is a growing technical competency differentiator; programming visits every 1–3 months generate recurring revenue
• New outpatient visit — movement disorders evaluation: CPT 99205 (new patient, high complexity); professional fee $280–$450; 4.11 wRVU; comprehensive Parkinson's evaluation (UPDRS Part III motor scoring, cognitive assessment, non-motor symptoms review, medication optimization); typical new patient movement disorders visit runs 60–90 minutes
• Established outpatient visit: CPT 99214 or 99215; professional fee $180–$280; quarterly or biannual Parkinson's follow-up; medication titration, DBS parameter review, fall risk assessment, non-motor progression monitoring; high volume of established patients generates steady E&M revenue floor
• Genetic testing coordination (LRRK2, GBA, PRKN): CPT 81401 (multigene panel); not directly billed by neurologist but drives patient engagement and referral to specialty programs with genetic counseling infrastructure

Botulinum toxin buy-and-bill economics

The financial engine of high-earning movement disorders practices is botulinum toxin buy-and-bill. A movement disorders specialist with 200 active dystonia/spasticity patients receiving toxin injections every 12–16 weeks generates 600–800 botulinum toxin injection sessions per year. At 200 units of onabotulinumtoxinA per session (wholesale ~$1,100 per 200-unit vial), the physician purchases toxin at ~$1,100 and is reimbursed at Medicare's allowed amount (approximately $1,500–$2,000 for J0585 at 200 units, depending on MAC jurisdiction). Net margin per session: $400–$900. At 700 sessions/year: $280,000–$630,000 in annual drug margin before professional injection fee. This buy-and-bill margin — available at practices with in-office toxin purchasing and proper DMERC billing infrastructure — is the single largest income differentiator between movement disorders specialists at different practice models.

Geographic variation

• Major academic movement disorders centers (UCSF, Cleveland Clinic, Mayo, MGH, Columbia, Penn, Northwestern): $290,000–$420,000; Parkinson's Foundation Center of Excellence designation; research infrastructure; fellowship program; PSLF-eligible
• Sun Belt and high-aging-population markets (FL, AZ, SC, NC): $360,000–$510,000; highest Parkinson's prevalence per capita; unmet demand for movement disorders specialists; community neurology practices with movement disorders focus can build large panels rapidly; botulinum toxin buy-and-bill margin amplifies community practice income significantly above academic
• Urban and suburban markets nationally: $330,000–$470,000; employed neurology group or private practice; movement disorders referral source from geriatric neurologists and primary care; DBS programming center drives complex referrals
• Rural markets: Very limited access to movement disorders specialists; telehealth Parkinson's management programs growing; rural on-site movement disorders positions command $380,000–$500,000+

What we see at Ava Health

Movement disorders specialists are among the most actively sought neurological subspecialists in our recruiting database. The Parkinson's disease prevalence curve — driven by population aging and the growing recognition of Parkinson's as a nationwide public health priority — creates accelerating demand that the fellowship pipeline cannot satisfy. Physicians with both DBS programming experience and botulinum toxin injection volume are the highest-demand profile: they bring the full procedural revenue stack to a community neurology program. The most common scenario driving openness to outreach: academic movement disorders specialists who have built their research program but are re-evaluating the academic salary ceiling relative to what an employed community or private practice role with buy-and-bill toxin administration can generate.

Related: Neurologist Salary Guide, Neurohospitalist Salary Guide, Geriatrician Salary Guide, Psychiatrist Salary Guide.